Evaluation of preoperative cutaneous fistula as a risk factor for recurrence of thyroglossal duct cyst in children.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 04 02 2022
accepted: 17 05 2022
revised: 06 05 2022
pubmed: 8 6 2022
medline: 9 8 2022
entrez: 7 6 2022
Statut: ppublish

Résumé

The aim of this study is to investigate the risk factors for recurrence after thyroglossal duct cyst (TGDC) surgery, differentiating between infections with and without a cutaneous fistula. This is a retrospective analysis of all paediatric TGDC in a tertiary care centre with at least 2 years of postoperative follow-up. One hundred and thirty-one patients met the inclusion criteria of the study. A multivariate analysis was performed to analyse the main risk factors for recurrence (presence of a fistula, infection, age). 116/131 patients were managed primarily in our institution; 15 patients had previously been operated on in another centre. The recurrence rate was 4.3% (5/116) when the patient was operated on in our institution at the first operation, and overall, recurrence of TGDC occurred in 20/131 (15.3%) patients. Age was not a risk factor for recurrence (p = 0.596). Two or more episodes of preoperative TGDC infection were a statistically significant risk factor in univariate analysis (p = 0.021) but not in multivariate analysis adjusted for age and the presence of a cutaneous fistula (p = 0.385). In multivariate analysis, cutaneous fistula formation was an independent risk factor for recurrence when adjusted for age and preoperative TGDC infection (Hazard ratio = 5.35; p = 0.011). A preoperative cutaneous fistula was a critical and independent risk factor for recurrence of operated TGDC, whereas age and TGDC infection were not identified as risk factors for recurrence after surgery. This information should be given to patients and parents before surgery. • The risk factors for recurrence after thyroglossal duct cyst surgery described in the literature are preoperative infection and young age, but this is not supported by strong evidence. • The role of cutaneous fistula formation is unclear. • The main risk factor for recurrence of TGDC is the presence of a preoperative cutaneous fistula, with an estimated hazard ratio of 4.95 (p = 0.016) in multivariate analysis. • The presence of two preoperative infections was also associated with a greater risk of recurrence in univariate analysis; age and gender were not associated with an increased risk of recurrence.

Identifiants

pubmed: 35670869
doi: 10.1007/s00431-022-04511-x
pii: 10.1007/s00431-022-04511-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3049-3054

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Todd NW (1993) Common congenital anomalies of the neck: embryology and surgical anatomy. Surg Clin North Am 73:599–610. https://doi.org/10.1016/S0039-6109(16)46076-7
doi: 10.1016/S0039-6109(16)46076-7 pubmed: 8378812
Sachpekidis C, Dettmer MS, Weidner S et al (2017) 18F-FDG PET/CT of Papillary carcinoma in a lateral thyroglossal duct cyst. Clin Nucl Med 42:e371–e374. https://doi.org/10.1097/RLU.0000000000001712
doi: 10.1097/RLU.0000000000001712 pubmed: 28525461
Chang Y-S, Su H-H, Ho S-P (2016) Adenosquamous carcinoma arising from a thyroglossal duct cyst: a case report. Oncol Lett 11:2668–2672. https://doi.org/10.3892/ol.2016.4262
doi: 10.3892/ol.2016.4262 pubmed: 27073536 pmcid: 4812427
Sistrunk WE (1920) The surgical treatment of cyst of the thyroglossal tract. Ann Surg 71:121–122. https://doi.org/10.1097/00000658-192002000-00002
doi: 10.1097/00000658-192002000-00002 pubmed: 17864229 pmcid: 1410396
Rohof D, Honings J, Theunisse HJ et al (2015) Recurrences after thyroglossal duct cyst surgery: results in 207 consecutive cases and review of the literature: Recurrences after thyroglossal duct cyst surgery. Head Neck 37:1699–1704. https://doi.org/10.1002/hed.23817
doi: 10.1002/hed.23817 pubmed: 24985922
Ducic Y, Chou S, Drkulec J et al (1998) Recurrent thyroglossal duct cysts: a clinical and pathologic analysis. Int J Pediatr Otorhinolaryngol 44:47–50. https://doi.org/10.1016/S0165-5876(98)00041-X
doi: 10.1016/S0165-5876(98)00041-X pubmed: 9720680
Marianowski R (2003) Risk factors for thyroglossal duct remnants after Sistrunk procedure in a pediatric population. Int J Pediatr Otorhinolaryngol 67:19–23. https://doi.org/10.1016/S0165-5876(02)00287-2
doi: 10.1016/S0165-5876(02)00287-2 pubmed: 12560145
Pastore V, Bartoli F (2014) “Extended” Sistrunk procedure in the treatment of recurrent thyroglossal duct cysts: a 10-year experience. Int J Pediatr Otorhinolaryngol 78:1534–1536. https://doi.org/10.1016/j.ijporl.2014.06.029
doi: 10.1016/j.ijporl.2014.06.029 pubmed: 25048858
Batazzi A, Leng S, Ghionzoli M et al (2019) Thyroglossal duct cyst: factors affecting cosmetic outcome and recurrence. Pediatr Int 61:1020–1024. https://doi.org/10.1111/ped.13955
doi: 10.1111/ped.13955 pubmed: 31282046
Kepertis C, Anastasiadis K, Lambropoulos V et al (2015) Diagnostic and surgical approach of thyroglossal duct cyst in children: ten years data review. J Clin Diagn Res JCDR 9:PC13-15. https://doi.org/10.7860/JCDR/2015/14190.6969
doi: 10.7860/JCDR/2015/14190.6969 pubmed: 26813309
Huang J, Osterbauer B, Koempel J (2018) Prevalence of an intact hyoid bone at revision excision of a thyroglossal duct remnant. Int J Pediatr Otorhinolaryngol 113:131–133. https://doi.org/10.1016/j.ijporl.2018.07.047
doi: 10.1016/j.ijporl.2018.07.047 pubmed: 30173971

Auteurs

Céline Bory (C)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, Marseille, France.

Marie-Eva Rossi (ME)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, Marseille, France.

Olivier Bory (O)

Department of Ambulatory Medicine, Université de Paris, Assistance Publique - Hôpitaux de Paris - Louis Mourier, Paris, France.

Richard Nicollas (R)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, Marseille, France.

Eric Moreddu (E)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, Marseille, France. eric.moreddu@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH